Plasma Cell Priming
Plasma Cell Priming
批准号:
9403332
负责人:
David M Allman
金额:
$24.15万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2019-05-31
关键词:
AddressAntibodiesApoptoticAutoantibodiesAutoimmune DiseasesAutoimmunityAutomobile DrivingB cell differentiationB-LymphocytesBCL1 OncogeneBacteriaBiochemicalBiochemical PathwayBiological MarkersBloodCell CountCell divisionCellsCouplesCuesDataEnsureEvaluationEventFRAP1 geneFamilyGene DeletionGene ExpressionGene Expression ProfileGene Expression RegulationGenerationsGenesGoalsHost DefenseImmunityIn SituKineticsKnowledgeLupusMediatingMitosisMolecularPathogenicityPhasePhosphotransferasesPlasma CellsPlayPopulationPositioning AttributeProcessProteinsReceptor SignalingRestRoleSignal PathwaySignal TransductionSinusSpleenTSC1 geneTestingTherapeuticTranscriptTransgenesTranslatingTranslationsUp-RegulationWorkXBP1 geneadenoviral-mediatedcombatcytokinedifferentiated B cellexperimental studyextracellularin vitro Modelin vivoinsightmTOR inhibitionnovel strategiesplasma cell differentiationprogramsreceptorreceptor expressionresponsetranscription factortranscriptome sequencing
中文摘要
项目摘要
自身反应性抗体产生的细胞和分子事件
自身免疫性仍然知之甚少。值得注意的是,边缘区(MZ)B细胞是
富含自身反应性B细胞,并且已知产生抗体分泌血浆
与其他B细胞相比,这个R21项目的中心是
了解MZ B细胞产生血浆的分子机制
细胞与加速动力学,重点是定义细胞外的线索和相关的
引发MZ B细胞分化的细胞内信号传导途径。中央
指导这项工作的假设是mTOR/mTORC 1激酶,一种新兴的生物标志物,
在狼疮和相关的自身免疫性疾病中,BAFF受体信号传导和
相关浆细胞基因的表达以促进抗体的快速诱导
合成.为了验证这一假设,我们将:1)定义mTOR/mTORC 1信号传导的作用
在浆细胞引发中,以及2)探索驱动血浆的细胞外输入的身份
原位细胞引发。这些研究将增进对这些现象背后的过程的了解。
所有浆细胞的产生,包括那些分泌致病性自身反应的浆细胞,
抗体的
英文摘要
Project summary
The cellular and molecular events underlying the generation of self-reactive antibodies in
autoimmunity remain poorly understood. Notably, marginal zone (MZ) B cells are
enriched for self-reactive B cells, and are known to generate antibody-secreting plasma
cells exceptionally quickly compared to other B cells. This R21 project centers on
understanding the molecular mechanisms through which MZ B cells generate plasma
cells with accelerated kinetics, with a focus on defining extracellular cues and associated
intracellular signaling pathways that prime MZ B cells for differentiation. The central
hypothesis guiding this work is that the mTOR/mTORC1 kinase, an emerging biomarker
in lupus and related autoimmune diseases, couples BAFF-receptor signaling and
expression of relevant plasma cell genes to facilitate rapid induction of antibody
synthesis. To test this hypothesis we will: 1) Define the role of mTOR/mTORC1 signaling
in plasma cell priming, and 2) Explore the identity of extracellular inputs driving plasma
cell priming in situ. These studies will enhance knowledge of the processes underlying
the generation of all plasma cells including those secreting pathogenic self-reactive
antibodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
-
批准号:10637251
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
The Notch Pathway in Antigen Design
-
批准号:10575892
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10441466
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10240081
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10215534
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10443660
-
项目类别:
-
资助金额:$68.88万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10652461
-
项目类别:
-
资助金额:$65.66万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Epigenetic Control of Plasma Cell Differentiation
-
批准号:9105812
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9111850
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9315100
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:8772548
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8387887
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8680129
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8508182
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:9096003
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8868901
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:8066726
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:7983146
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7812028
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7268827
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
海外基金